3/12
04:42 pm
krro
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
High
Report
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/12
04:05 pm
krro
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
High
Report
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
3/9
07:58 am
krro
Korro Announces Oversubscribed $85 Million Private Placement [Yahoo! Finance]
High
Report
Korro Announces Oversubscribed $85 Million Private Placement [Yahoo! Finance]
3/9
07:30 am
krro
Korro Announces Oversubscribed $85 Million Private Placement
Medium
Report
Korro Announces Oversubscribed $85 Million Private Placement
2/25
04:05 pm
krro
Korro to Present at the TD Cowen 46th Annual Health Care Conference
Low
Report
Korro to Present at the TD Cowen 46th Annual Health Care Conference
2/20
07:27 am
krro
Korro Bio (NASDAQ:KRRO) was upgraded by analysts at Clear Str Llc from a "hold" rating to a "strong-buy" rating.
Medium
Report
Korro Bio (NASDAQ:KRRO) was upgraded by analysts at Clear Str Llc from a "hold" rating to a "strong-buy" rating.
2/18
08:03 pm
krro
Korro Bio (NASDAQ:KRRO) was given a new $18.00 price target on by analysts at Raymond James Financial, Inc..
Low
Report
Korro Bio (NASDAQ:KRRO) was given a new $18.00 price target on by analysts at Raymond James Financial, Inc..
2/17
08:00 am
krro
Korro Bio (NASDAQ:KRRO) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Low
Report
Korro Bio (NASDAQ:KRRO) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
2/2
10:00 am
krro
H.C. Wainwright Flag KRRO-121 as Independent Value Driver for Korro Bio, Inc. (KRRO) [Yahoo! Finance]
Low
Report
H.C. Wainwright Flag KRRO-121 as Independent Value Driver for Korro Bio, Inc. (KRRO) [Yahoo! Finance]
1/30
07:12 pm
krro
Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength? [Yahoo! Finance]
Low
Report
Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength? [Yahoo! Finance]
1/29
03:57 pm
krro
Korro Bio, Inc. (KRRO) Analyst/Investor Day Transcript [Seeking Alpha]
Low
Report
Korro Bio, Inc. (KRRO) Analyst/Investor Day Transcript [Seeking Alpha]
1/29
07:03 am
krro
Korro Bio (NASDAQ:KRRO) was given a new $15.00 price target on by analysts at Chardan Capital.
Medium
Report
Korro Bio (NASDAQ:KRRO) was given a new $15.00 price target on by analysts at Chardan Capital.
1/28
10:12 am
krro
Korro Bio (NASDAQ:KRRO) had its "market perform" rating reaffirmed by analysts at William Blair.
Medium
Report
Korro Bio (NASDAQ:KRRO) had its "market perform" rating reaffirmed by analysts at William Blair.
1/28
10:12 am
krro
Korro Bio (NASDAQ:KRRO) had its "market perform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Medium
Report
Korro Bio (NASDAQ:KRRO) had its "market perform" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/20
11:48 am
krro
Korro Bio, Inc. (KRRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript [Seeking Alpha]
Neutral
Report
Korro Bio, Inc. (KRRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript [Seeking Alpha]
1/20
08:00 am
krro
Korro to Host Virtual Analyst Day on January 27, 2026
Low
Report
Korro to Host Virtual Analyst Day on January 27, 2026
1/14
05:17 pm
krro
Flashpoint Therapeutics Appoints Venkat R. Krishnamurthy, Ph.D. as Chief Scientific Officer [Yahoo! Finance]
Medium
Report
Flashpoint Therapeutics Appoints Venkat R. Krishnamurthy, Ph.D. as Chief Scientific Officer [Yahoo! Finance]
1/13
04:05 am
krro
Korro Bio (NASDAQ:KRRO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Korro Bio (NASDAQ:KRRO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/8
08:00 am
krro
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference